Search clinical trials for: GMI-1271

Total 1796 results

Centocor, Inc.
Centocor BV

Completed

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

Multiple Sclerosis
Assistance Publique Hopitaux De Marseille

Recruiting

Addition of Platelet Rich Plasma (PRP) in Microfat Lipofilling (MG) in the Treatment of Cranial Flap Scars: A Randomized, Double-blind, Superiority Study (LIPOPREP)

Facial Lipofilling

France
Leiden University Medical Center

Recruiting

Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine (MILESTONE)

COVID-19 | Vaccination; Infection

Netherlands
ModernaTX, Inc.
Lead Scientific and Operating Center: Julius Clinical Research

Active, not recruiting

A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

Myocarditis, Pericarditis

Denmark, Norway, Spain, United Kingdom
Johnson & Johnson Pte Ltd

Completed

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries (MARCOPOLO)

Plaque Psoriasis

Taiwan, Korea, Republic of, Malaysia, Singapore, Indonesia
Vanderbilt University Medical Center

Approved for marketing

Humanitarian Device Exemption (Dystonia IRB)

Dystonia

United States
Lantheus Medical Imaging

Withdrawn

Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing (LMI1195-201)

Heart Failure

United States
Jewish General Hospital

Completed

Randomized Controlled Trial of the Meaning-Making Intervention (MMi)

Advanced Cancer

Canada
Marmara University

Recruiting

Graded Motor Imagery Training in Shoulder Impingement Syndrome

Pain | Shoulder Impingement Syndrome

Turkey
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects

Healthy

United States
Precision Life Sciences Group

Completed

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Glioblastoma Multiforme

United States
Umeå University

Not yet recruiting

Risk of COVID-19 Infection After Vaccination

Covid19 | Vaccination; Infection
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Anorexia | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8

United States
HealthPartners Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrolling by invitation

Weight Loss Clinical Decision Support (BMI-CDS)

Obesity | Diabetes Mellitus, Type 2

United States
Hope Medicine (Nanjing) Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

Androgenetic Alopecia

China
Lantheus Medical Imaging

Completed

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Heart Failure

United States
Taisho Pharmaceutical R&D Inc.
Yale University

Completed

Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects

Healthy

United States
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis

Cystic Fibrosis

Netherlands, United Kingdom
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers

Acute Ischemic Stroke | Cerebral Edema

China
Hamamatsu University
Japan Agency for Medical Research and Development

Unknown

A Trial of TTA-121 on Autism Spectrum Disorder

Autism Spectrum Disorder

Japan
Amgen

Completed

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Multiple Myeloma

United States, Canada
Vertex Pharmaceuticals Incorporated

Completed

A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

Cystic Fibrosis

United States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
University of Thessaly

Recruiting

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture (Gr-GFI)

Hip Fractures | Frailty Syndrome

Greece
Sykehuset Innlandet HF
University of Oslo

Completed

Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia

Neurocognitive Disorders | Schizophrenia

Norway
Carnegie Mellon University
University of Pittsburgh

Active, not recruiting

Evaluating FDA's Proposed Patient Medication Information Handout

Attitude | Knowledge

United States
VA Office of Research and Development

Completed

Web-Based Delivery of MOVE! to Veterans With Serious Mental Illness (SMI) (Web-MOVE!)

Psychotic Disorders | Obesity | Health Behaviors

United States
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Primary Care Clinical Practice Elements and Improving Overweight Children's Weight Status

Overweight | Childhood Obesity

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

Bacterial Infections

United States
Amgen

Completed

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada
University of Minnesota

Completed

Brief Motivational Interviewing (BMI)

Motivational Interviewing, BMI, OHI

United States
Nationwide Children's Hospital

Completed

Obesity Guidelines for Outpatient Surgery

Obesity

United States
GE Healthcare
Quintiles, Inc.; Physician Reference Laboratory

Completed

Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers

Healthy

United States
Terence Flotte
Massachusetts General Hospital; University of Massachusetts, Worcester

Active, not recruiting

A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease

Tay-Sachs Disease | Sandhoff Disease

United States
Dennis Turner, M.D.
National Institute of Neurological Disorders and Stroke (NINDS); Duke University and other collaborators

Active, not recruiting

Closed Loop DBS Implanted RC+S Study

Parkinson Disease

United States
Northwestern University

Completed

Stability of the Medial Pivot Total Knee Prosthesis

Osteoarthritis of Knee

United States
ModernaTX, Inc.

Active, not recruiting

A Study of Modified mRNA Vaccines in Healthy Adults

Cytomegalovirus | SARS-CoV-2 | Seasonal Influenza | Respiratory Syncytial Virus

United States
Genentech, Inc.

Recruiting

Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Colorectal Cancer | Non-Small Cell Lung Cancer

Korea, Republic of, Australia, Canada, United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

Pneumonia

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Cystic Fibrosis

United States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
Jewish General Hospital
McGill University Health Centre/Research Institute of the McGill University...

Completed

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

Advanced Cancer

Canada
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease (STRIDE 2)

Dry Eye Syndromes | Keratoconjunctivitis Sicca

United States
Kala Pharmaceuticals, Inc.

Completed

Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema (Molokini)

Diabetic Macular Edema | Retinal Vein Occlusion

United States
Chang Gung Memorial Hospital
Medigen Vaccine Biologics Corp.

Active, not recruiting

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

COVID-19 | Breakthrough Infection

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine

Covid19 | SARS-CoV2 Infection

United States
Scioto Biosciences, Inc.

Completed

28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder

Autistic Disorder

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Safety and PK Study of IV TP-271

Bacterial Infections

United States
Dong-A ST Co., Ltd.

Completed

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

Diabetes Mellitus, Type 2

United States
Centocor, Inc.

Completed

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Psoriasis
BioNTech SE
Pfizer

Completed

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

COVID-19 | SARS-CoV-2 Infection

United States, Brazil, South Africa, Germany, Canada, Israel

Search clinical trials for: GMI-1271

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations